cefixime has been researched along with cefpodoxime proxetil in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (55.56) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andremont, A; Bourneix, C; Chachaty, E; Corthier, G; Depitre, C; Mario, N; Saulnier, P | 1 |
| Clausen, CR; Del Beccaro, MA; Duncan, NO; Inglis, AF; Mendelman, PM; Richardson, MA; Stull, TL | 1 |
| Asmar, BI; Dajani, AS; Del Beccaro, MA; Mendelman, PM | 1 |
| Rodriguez, WJ; Wiedermann, BL | 1 |
| Itokazu, GS; Karavokiros, KT; Schatz, BS; Taeubel, MA | 1 |
| Jayarama Reddy, S; Reddy, TM; Sreedhar, M | 1 |
| Ahmed, M; Arzuman, SA; Hossain, J; Mehdi, H; Shakur, MS | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
2 review(s) available for cefixime and cefpodoxime proxetil
| Article | Year |
|---|---|
The role of newer oral cephalosporins, fluoroquinolones, and macrolides in the treatment of pediatric infections.
Topics: Administration, Oral; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Bacterial Infections; Cefixime; Cefotaxime; Cefpodoxime Proxetil; Cefprozil; Ceftibuten; Ceftizoxime; Cefuroxime; Cephalosporins; Child; Clarithromycin; Fluoroquinolones; Humans | 1994 |
Comparison of cefprozil, cefpodoxime proxetil, loracarbef, cefixime, and ceftibuten.
Topics: Bacterial Infections; Cefixime; Cefotaxime; Cefpodoxime Proxetil; Cefprozil; Ceftibuten; Ceftizoxime; Cephalosporins; Humans; Microbial Sensitivity Tests; Prodrugs; Randomized Controlled Trials as Topic | 1996 |
4 trial(s) available for cefixime and cefpodoxime proxetil
| Article | Year |
|---|---|
Presence of Clostridium difficile and antibiotic and beta-lactamase activities in feces of volunteers treated with oral cefixime, oral cefpodoxime proxetil, or placebo.
Topics: Administration, Oral; Adult; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; beta-Lactamases; Cefixime; Cefotaxime; Cefpodoxime Proxetil; Ceftizoxime; Chromosomes, Bacterial; Clostridioides difficile; DNA, Bacterial; Enterotoxins; Feces; Humans; Prodrugs; Restriction Mapping | 1992 |
Bacteriology of acute otitis media: a new perspective.
Topics: Acute Disease; Adolescent; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Bacteria; Bacteriological Techniques; Cefixime; Cefotaxime; Cefpodoxime Proxetil; Ceftizoxime; Cephalosporins; Child; Child, Preschool; Clavulanic Acids; Drug Therapy, Combination; Haemophilus influenzae; Humans; Infant; Moraxella catarrhalis; Otitis Media; Prodrugs; Punctures; Recurrence; Single-Blind Method; Streptococcus pneumoniae; Tympanic Membrane | 1992 |
Comparison of cefpodoxime proxetil and cefixime in the treatment of acute otitis media in infants and children. Otitis Study Group.
Topics: Acute Disease; Adolescent; Anti-Infective Agents; Cefixime; Cefotaxime; Cefpodoxime Proxetil; Ceftizoxime; Child; Child, Preschool; Female; Follow-Up Studies; Humans; Infant; Male; Otitis Media, Suppurative; Prodrugs; Statistics as Topic; Treatment Outcome | 1994 |
Cefpodoxime proxetil compared with cefixime for treatment of typhoid fever in children.
Topics: Anti-Bacterial Agents; Cefixime; Cefpodoxime Proxetil; Ceftizoxime; Child; Child, Preschool; Double-Blind Method; Female; Humans; Infant; Male; Typhoid Fever | 2007 |
3 other study(ies) available for cefixime and cefpodoxime proxetil
| Article | Year |
|---|---|
Voltammetric behavior of cefixime and cefpodoxime proxetil and determination in pharmaceutical formulations and urine.
Topics: Cefixime; Cefpodoxime Proxetil; Ceftizoxime; Chemistry, Pharmaceutical; Electrochemistry; Pharmaceutical Preparations | 2003 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |